Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-10-05 Exercise |
2020-10-07 4:50 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
14,000 | $6.5 | 3,599,415 (Direct) |
View |
| 2020-10-05 Exercise |
2020-10-07 4:50 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
182,000 | $0 | 3,599,415 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 4:52 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 668,658 (Direct) |
View |
| 2020-09-29 Exercise |
2020-10-01 4:52 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
19,500 | $0 | 668,658 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 5:10 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
14,000 | $6.5 | 3,781,415 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 5:10 pm |
N/A 2025-07-01 |
BeiGene Ltd. | BGNE | Liang Howard CFO & Chief Strategy Officer |
182,000 | $0 | 3,781,415 (Direct) |
View |
| 2020-08-28 Exercise |
2020-09-01 4:41 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
3,000 | $29.49 | 728,822 (Direct) |
View |
| 2020-08-28 Exercise |
2020-09-01 4:41 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
39,000 | $0 | 728,822 (Direct) |
View |
| 2020-08-24 Option Award |
2020-08-26 4:51 pm |
N/A 2030-08-23 |
BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director |
27,482 | $0 | 27,482 (Direct) |
View |
| 2020-08-25 Option Award |
2020-08-25 5:55 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
59,390 | $248.49 | 18,524,373 (Direct) |
View |
| 2020-08-21 Option Award |
2020-08-24 5:47 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
64,176 | $230.18 | 18,464,983 (Direct) |
View |
| 2020-08-24 Option Award |
2020-08-24 5:47 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
59,390 | $239.1 | 18,464,983 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 7:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
40,000 | $230.18 | 18,341,417 (Direct) |
View |
| 2020-08-20 Option Award |
2020-08-20 7:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
64,176 | $234.99 | 18,341,417 (Direct) |
View |
| 2020-08-19 Option Award |
2020-08-20 7:28 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
64,176 | $234.88 | 18,341,417 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
7,000 | $31.59 | 900,839 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 5:02 pm |
N/A 2026-02-08 |
BeiGene Ltd. | BGNE | Chen Timothy Yung-Cheng Director |
91,000 | $0 | 900,839 (Direct) |
View |
| 2020-08-11 Gift |
2020-08-12 4:38 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
1,560 | $0 | 11,887,429 (Direct) |
View |
| 2020-07-29 Exercise |
2020-07-31 4:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $29.49 | 980,502 (Direct) |
View |
| 2020-07-29 Exercise |
2020-07-31 4:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
1,500 | $160.4 | 980,502 (Direct) |
View |
| 2020-07-29 Exercise |
2020-07-31 4:24 pm |
N/A 2026-09-02 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
39,000 | $0 | 980,502 (Direct) |
View |
| 2020-07-15 Option Award |
2020-07-17 5:23 pm |
N/A N/A |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
14,584,180 | $14.23 | 30,745,118 (Indirect) |
View |
| 2020-07-15 Option Award |
2020-07-16 5:18 pm |
N/A N/A |
BeiGene Ltd. | BGNE | AMGEN INC 10% Owner |
29,614,832 | $14.23 | 236,249,845 (Direct) |
View |
Ownership |
2020-07-14 09:00 am |
N/A N/A |
BeiGene Ltd. | BGNE | HILLHOUSE CAPITAL ADVISORS LTD. HILLHOUSE CAPITAL MANAGEMENT LTD. 10% Owner |
0 | $0 | 147,035,258 (Indirect) |
View |
| 2020-07-07 Exercise |
2020-07-09 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
3,921 | $160.4 | 558,427 (Direct) |
View |
| 2020-07-07 Exercise |
2020-07-09 4:43 pm |
N/A 2028-06-25 |
BeiGene Ltd. | BGNE | Huang Jane CMO, Hematology |
50,973 | $0 | 558,427 (Direct) |
View |